Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks
Ontology highlight
ABSTRACT: Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks
PROVIDER: PRJNA867348 | ENA |
REPOSITORIES: ENA
ACCESS DATA